Adam Hochron

In the world of pulmonary conditions idiopathic pulmonary fibrosis is among the rarest, and up until recently there were no treatments available to help these patients. With the approval of OFEV there is now something that can be done while more research is conducted.

With the number of patients diagnosed with COPD continuing to grow new treatment options are also needed to help these patients maintain a sustainable quality of life.

While the days of the solo practitioner hanging a shingle in their hometown winds to an end the healthcare community is now turning its attention to how teams can provide the best level of care to patients.

Even as the annual CHEST meeting moved across the border to Montreal the goal of the event was the same, to provide education to attendees on a wide range of topics.

Post traumatic stress disorder is a serious condition that affects not only our country's veterans but other people who have experienced difficult events in their lives. The implications can stretch to various parts of their lives including other areas of their health care.

At the annual CHEST conference in Montreal one of the sessions looked at new guidelines for treating patients with sepsis in emergency medical care.

With each small step made progress towards treatment and prevention of progressive multiple sclerosis creeps closer to becoming a reality, an idea which just a few years ago seemed almost inconceivable.

While there are already several medications and treatments on the market for relapsing multiple sclerosis there continues to be a concerted effort to develop more in an effort to help as many patients as possible.

Recent research suggests that treatment with teriflunomide may slow brain atrophy in patients with relapsing multiple sclerosis.

Patients with multiple sclerosis are no strangers to taking medication for their condition at various times. A new autoinjector recently approved by the FDA hopes to help patients with that process with updated technology and other features to make the process more streamlined and less painful.

The guy microbiome is being studied across the healthcare spectrum as more is learned about this part of a person's anatomy. What it could mean for the treatment of multiple sclerosis has yet to be determined.

There are many factors that can contribute to a person's condition with multiple sclerosis. A recent study looked at what role melatonin can play in the process.

Earlier this year the Consortium of Multiple Sclerosis Centers held its annual conference in Indianapolis with more than 2000 people in attendance. All with the same goal of improving the care they provide their patients with this difficult disease.

There are many factors that patients diagnosed with multiple sclerosis need to consider when managing their condition. While the physical symptoms can be the highest priority, quality of life is an area which is gaining greater recognition in the field.

As the number of treatment options for multiple sclerosis continues to grow patients and their doctors are left to find the right choice for them in order to manage the disease as successfully as possible. This can be a long process that can have a long lasting impact on their overall health.

Tecfidera has been on the market for a few years to help treat relapsing remitting multiple sclerosis and through extended studies and watching the market positive results have been seen by patients using the oral treatment.

Even as more medications are developed for relapsing remitting multiple sclerosis patients those with the primary progressive form have been left waiting for news on their condition. According to recent studies the first step in that process may soon be coming to the market.

With doctors having to take on more administrative work in addition to their patient care duties finding systems that can help them accomplish their goals without adding more time consuming tasks can be crucial.

Newer medications for the treatment of multiple sclerosis have been developed in recent years but for some patients interferon remains the starting point for pharmaceutical options.

Just as overactive bladder issues and constipation are an issue for patients with multiple sclerosis, mirabegron is a popular medication in the general population for managing these issues. At the NYU Langone Medical Center Comprehensive Care Center patients receive treatment from a wide variety of healthcare professionals in order to get the best results possible for their condition.

As patients with multiple sclerosis get older memory loss becomes a growing problem. Ways to slow that process including digital technology to help keep a patient's brain sharp.

Optic neuritis is linked to multiple sclerosis and a treatment to help patients with this condition continues to work its way through the research and approval process. Unlike other areas of multiple sclerosis treatment there is no singular way to measure or determine cognitive impairment in patients.

In 1992 the European Committee For Treatment And Research in Multiple Sclerosis met in Barcelona with 200 people in attendance. Twenty three years later the same conference was held in the same city with more than 9000 people in attendance and more than 1000 abstracts submitted.

While many areas of multiple sclerosis treatment have made progress in recent years working to help patients through issues with cognition is still an inexact science though work is being done to correct that.

The ECTRIMS conference may be based in Europe but as the conference has grown so has its global impact on multiple sclerosis treatment. With topics ranging from newly approved therapies to those in the pipeline to those not yet ready for testing there is lots to learn in the yearly event.

In the world of multiple sclerosis treatment the relapsing remitting form of the disease is well ahead of the primary progressive form.

With some patients being treated for multiple sclerosis with Aubagio for more than a decade questions have been raised about the safety of the treatment for such a long period of time. Further research has shown it to still be safe for the people who need it most.

It can be easy to look at the treatment of multiple sclerosis and stop at the physical symptoms of the disease. For patients living with the condition their daily lives are about more than the symptoms and making them work within their own individual challenges.

As the hub of military medicine in the United States Walter Reed National Military Medical Center combines the talents of both military and civilian medical personnel to provide care for nearly one million patients every year.

As the name suggests sudden cardiac death is a condition that can strike without any warning. Because of this it is important to identify potentially at risk patients so they can get the treatment they need in a timely manner.